Biological functions of Mycobacterium tuberculosis-specific CD4 +T cells were impaired by tuberculosis pleural fluid

Immunology Letters

Volumn 138, Issue 2, 2011, Pages 113-121

  Li, Qin ^a   Li, Li ^a   Liu, Yun ^a   Fu, Xiaoying ^a   Wang, Hui ^a   Lao, Suihua ^b   yang, Binyan ^a   Wu, Changyou ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Chest Hospital of Guangzhou   (China)

Author keywords

CD4 +T cells; Pleural fluid; Tuberculosis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CELL DIVISION; CELL INTERACTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MALE; MYCOBACTERIUM TUBERCULOSIS; PLEURA FLUID; PRIORITY JOURNAL; TUBERCULOUS PLEURISY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; ANTIBODIES, NEUTRALIZING; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BODY FLUIDS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2; LUNG; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; TRANSFORMING GROWTH FACTOR BETA; TUBERCULOSIS, PLEURAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79959555513     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2011.03.008     Document Type: Article

References (45)

1. Porcel J.M. Tuberculous pleural effusion. Lung 2009, 187:263-270.
2. Ferrer J. Pleural tuberculosis. Eur Respir J 1997, 10:942-947.
3. Khalil R.Y., Khalil M.M. Flow cytometric study of T-cell subsets in lymphocytic pleural effusions. Cytometry 1997, 30:204-205.
4. Okamoto M., Hasegawa Y., Hara T., Hashimoto N., Imaizumi K., Shimokata K., et al. T-helper type 1/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions. Chest 2005, 128:4030-4035.
5. Barnes P.F., Fong S.J., Brennan P.J., Twomey P.E., Mazumder A., Modlin R.L. Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. J Immunol 1990, 145:149-154.
6. Barnes P.F., Lu S., Abrams J.S., Wang E., Yamamura M., Modlin R.L. Cytokine production at the site of disease in human tuberculosis. Infect Immun 1993, 61:3482-3489.
7. Zhang M., Lin Y., Iyer D.V., Gong J., Abrams J.S., Barnes P.F. T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun 1995, 63:3231-3234.
8. Robinson D.S., Ying S., Taylor I.K., Wangoo A., Mitchell D.M., Kay A.B., et al. Evidence for a Th1-like bronchoalveolar T-cell subset and predominance of interferon-gamma gene activation in pulmonary tuberculosis. Am J Respir Crit Care Med 1994, 149:989-993.
9. Kaufmann S.H. How can immunology contribute to the control of tuberculosis?. Nat Rev Immunol 2001, 1:20-30.
10. Cooper A.M. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 2009, 27:393-422.
11. Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., Bloom B.R. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993, 178:2249-2254.
12. Newport M.J., Huxley C.M., Huston S., Hawrylowicz C.M., Oostra B.A., Williamson R., et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996, 335:1941-1949.
13. Jouanguy E., Lamhamedi-Cherradi S., Altare F., Fondaneche M.C., Tuerlinckx D., Blanche S., et al. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis. J Clin Invest 1997, 100:2658-2664.
14. Almeida A.S., Lago P.M., Boechat N., Huard R.C., Lazzarini L.C., Santos A.R., et al. Tuberculosis is associated with a down-modulatory lung immune response that impairs Th1-type immunity. J Immunol 2009, 183:718-731.
15. Hernandez-Pando R., Orozco H., Aguilar D. Factors that deregulate the protective immune response in tuberculosis. Arch Immunol Ther Exp (Warsz) 2009, 57:355-367.
16. Jozefowski S., Sobota A., Kwiatkowska K. How Mycobacterium tuberculosis subverts host immune responses. Bioessays 2008, 30:943-954.
17. Boussiotis V.A., Tsai E.Y., Yunis E.J., Thim S., Delgado J.C., Dascher C.C., et al. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 2000, 105:1317-1325.
18. Pai R.K., Convery M., Hamilton T.A., Boom W.H., Harding C.V. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion. J Immunol 2003, 171:175-184.
19. Noss E.H., Pai R.K., Sellati T.J., Radolf J.D., Belisle J., Golenbock D.T., et al. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol 2001, 167:910-918.
20. Kang P.B., Azad A.K., Torrelles J.B., Kaufman T.M., Beharka A., Tibesar E., et al. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J Exp Med 2005, 202:987-999.
21. Malik Z.A., Iyer S.S., Kusner D.J. Mycobacterium tuberculosis phagosomes exhibit altered calmodulin-dependent signal transduction: contribution to inhibition of phagosome-lysosome fusion and intracellular survival in human macrophages. J Immunol 2001, 166:3392-3401.
22. Bonecini-Almeida M.G., Ho J.L., Boechat N., Huard R.C., Chitale S., Doo H., et al. Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis. Infect Immun 2004, 72:2628-2634.
23. Gong J.H., Zhang M., Modlin R.L., Linsley P.S., Iyer D., Lin Y., et al. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun 1996, 64:913-918.
24. Hwu P., Du M.X., Lapointe R., Do M., Taylor M.W., Young H.A. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol 2000, 164:3596-3599.
25. Sun C.X., Zhong H., Mohsenin A., Morschl E., Chunn J.L., Molina J.G., et al. Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. J Clin Invest 2006, 116:2173-2182.
26. Huszar E., Vass G., Vizi E., Csoma Z., Barat E., Molnar V.G., et al. Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma. Eur Respir J 2002, 20:1393-1398.
27. Hasko G., Linden J., Cronstein B., Pacher P. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 2008, 7:759-770.
28. Li Q., Li L., Liu Y., Fu X.Y., Qiao D., Wang H., et al. Pleural fluid from tuberculous pleurisy inhibits the functions of T cells and the differentiation of Th1 cells via immunosuppressive factors. Cell Mol Immunol 2011, 1-9.
29. Aagaard C., Hoang T.T., Izzo A., Billeskov R., Troudt J., Arnett K., et al. Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose. PLoS One 2009, 4:e5930.
30. Barnes P.F., Samten B., Shams H., Vankayalapatib R. Progress in understanding the human immune responses to Mycobacterium tuberculosis. Tuberculosis (Edinb) 2009, 89(Suppl. 1):S5-S9.
31. Goletti D., Butera O., Bizzoni F., Casetti R., Girardi E., Poccia F. Region of difference 1 antigen-specific CD4+ memory T cells correlate with a favorable outcome of tuberculosis. J Infect Dis 2006, 194:984-992.
32. Souza M.C., Penido C., Costa M.F., Henriques M.G. Mechanisms of T-lymphocyte accumulation during experimental pleural infection induced by Mycobacterium bovis BCG. Infect Immun 2008, 76:5686-5693.
33. Schneider-Schaulies S., Dittmer U. Silencing T cells or T-cell silencing: concepts in virus-induced immunosuppression. J Gen Virol 2006, 87:1423-1438.
34. McChesney M.B., Fujinami R.S., Lerche N.W., Marx P.A., Oldstone M.B. Virus-induced immunosuppression: infection of peripheral blood mononuclear cells and suppression of immunoglobulin synthesis during natural measles virus infection of rhesus monkeys. J Infect Dis 1989, 159:757-760.
35. Jurado J.O., Alvarez I.B., Pasquinelli V., Martinez G.J., Quiroga M.F., Abbate E., et al. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis. J Immunol 2008, 181:116-125.
36. Pauli E.K., Schmolke M., Wolff T., Viemann D., Roth J., Bode J.G., et al. Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression. PLoS Pathog 2008, 4:e1000196.
37. Wang X., Li M., Zheng H., Muster T., Palese P., Beg A.A., et al. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol 2000, 74:11566-11573.
38. Schneider-Schaulies S., Schneider-Schaulies J. Measles virus-induced immunosuppression. Curr Top Microbiol Immunol 2009, 330:243-269.
39. Tishon A., Manchester M., Scheiflinger F., Oldstone M.B. A model of measles virus-induced immunosuppression: enhanced susceptibility of neonatal human PBLs. Nat Med 1996, 2:1250-1254.
40. Olobo J.O., Geletu M., Demissie A., Eguale T., Hiwot K., Aderaye G., et al. Circulating TNF-alpha, TGF-beta, and IL-10 in tuberculosis patients and healthy contacts. Scand J Immunol 2001, 53:85-91.
41. Moore K.W., de Waal M.R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001, 19:683-765.
42. Mellor A.L., Munn D.H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 2004, 4:762-774.
43. van der Sluijs K.F., Nijhuis M., Levels J.H., Florquin S., Mellor A.L., Jansen H.M., et al. Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia. J Infect Dis 2006, 193:214-222.
44. Lappas C.M., Rieger J.M., Linden J. A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells. J Immunol 2005, 174:1073-1080.
45. Odashima M., Bamias G., Rivera-Nieves J., Linden J., Nast C.C., Moskaluk C.A., et al. Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease. Gastroenterology 2005, 129:26-33.